Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Omalizumab for Atopic Dermatitis: Overtreatment or Lifesaver?

< BACK TO ARCHIVE


Papers: 29 Feb 2020 - 6 Mar 2020


Pharmacology/Drug Development

PAIN TYPE:
Itch


2020 Jan 01


JAMA Pediatr


http://www.ncbi.nlm.nih.gov/pubmed/31764954?dopt=Abstract


174


1

Omalizumab for Atopic Dermatitis: Overtreatment or Lifesaver?

Authors

Omalizumab for Atopic Dermatitis: Overtreatment or Lifesaver?
Wu A C
JAMA Pediatr. 2020 Jan 01; 174(1):15-16.
PMID: 31764954.
Read This Paper